Literature DB >> 22411290

Antiplatelet therapy. Intracoronary abciximab during PCI for STEMI.

Gregory B Lim.   

Abstract

Entities:  

Year:  2012        PMID： 22411290     DOI： 10.1038/nrcardio.2012.36

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial.

Authors:  Holger Thiele; Jochen Wöhrle; Rainer Hambrecht; Harald Rittger; Ralf Birkemeyer; Bernward Lauer; Petra Neuhaus; Oana Brosteanu; Peter Sick; Marcus Wiemer; Sebastian Kerber; Klaus Kleinertz; Ingo Eitel; Steffen Desch; Gerhard Schuler
Journal:  Lancet       Date:  2012-02-21       Impact factor: 79.321
  1 in total
  1 in total

1.  Newer agents in antiplatelet therapy: a review.

Authors:  Jennifer Yeung; Michael Holinstat
Journal:  J Blood Med       Date:  2012-06-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.